It is therefore reasonable to hypothesize that single-nucleotide polymorphisms (SNPs) in ADORA2A and ADORA2B can influence the activity of the adenosine A2 receptors, and further affect the susceptibility and progression of CHF. Here, ADORA2B is linked to congestive heart failure.